| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |